Roivant (ROIV) Form 144 shows 200,000‑share dispositions

Roivant Sciences Ltd. filed a Form 144 disclosing proposed dispositions of Common Shares under Rule 144.

Rhea-AI Filing Summary

Roivant Sciences Ltd. filed a Form 144 disclosing proposed dispositions of Common Shares under Rule 144. The filing lists 200,000 shares associated with an options exercise (grant date 04/20/2022) and shows past sales of 200,000 shares on 04/20/2026 and 200,000 shares on 05/22/2026.

Insights

Securities Attorney

Form 144 notifies the market of intended Rule 144 dispositions.

The filing lists proposed and completed dispositions of Common Shares tied to an option exercise dated 04/20/2022. Rule 144 filings are procedural notices that report planned sales by affiliates or persons relying on the exemption.

Cash‑flow treatment is not specified in the excerpt; subsequent transfer or sale details would appear in broker records or follow‑on filings.

Key Figures

Proposed sale: 200,000 shares Sale on 04/20/2026: 200,000 shares Sale on 05/22/2026: 200,000 shares +1 more

4 metrics

Proposed sale 200,000 shares Options exercise (grant date 04/20/2022) listed 06/24/2026

Sale on 04/20/2026 200,000 shares Reported sale by Eric Venker, value listed as $5,917,134.05

Sale on 05/22/2026 200,000 shares Reported sale by Eric Venker, value listed as $6,054,730.92

Listed transaction value $6,631,659.08 Amount shown adjacent to a 200,000 share line in the filing

Key Terms

Form 144, Rule 144, Wire

3 terms

Form 144 regulatory

"Filing lists proposed dispositions of Common Shares under Rule 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Rule 144 regulatory

"Securities To Be Sold | Options Exercise - Grant Date 04/20/2022"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Wire financial

"06/24/2026 | Wire"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Roivant's Form 144 for ROIV report?

The Form 144 reports proposed and completed dispositions of Common Shares. It lists a proposed 200,000‑share sale tied to an options exercise (grant date 04/20/2022) and prior sales of 200,000 shares on 04/20/2026 and 05/22/2026.

Who is named as seller in the ROIV Form 144?

The filing references Roivant Sciences Ltd. and shows sales executed by Eric Venker c/o Roivant Sciences Ltd. The listed broker/agent for one entry is Rockefeller Financial LLC at 45 Rockefeller Plaza, Floor 5, New York.

How many shares were sold or are proposed to be sold in the filing?

The excerpt shows amounts of 200,000 shares tied to an options exercise and two recorded sales of 200,000 shares each on 04/20/2026 and 05/22/2026. It does not aggregate totals beyond those line items.

Do the dollar amounts appear in the Form 144 excerpt?

Yes. The excerpt lists per‑transaction values adjacent to share counts, including $5,917,134.05, $6,054,730.92, and an entry showing $6,631,659.08 linked to a 200,000 share line in the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/24/2026 - 04:01 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001801917
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Roivant Sciences Ltd.
SEC File Number	001-40782
Address of Issuer	7TH FLOOR, 50 BROADWAY LONDON UNITED KINGDOM SW1H 0DB
Phone	441-295-5950
Name of Person for Whose Account the Securities are To Be Sold	Venker Eric
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Rockefeller Financial LLC 45 Rockefeller Plaza Floor 5 New York NY 10111	200000	6631659.08	719270385	06/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	06/24/2026	Options Exercise - Grant Date 04/20/2022	Roivant Sciences Ltd.			200000	06/24/2026	Wire

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Eeric Venker c/o Roivant Sciences Ltd. 7th Floor, 50 Broadway London X0 SW1H0DB	Common Shares	04/20/2026	200000	5917134.05
Eric Venker c/o Roivant Sciences Ltd. 7th Floor, 50 Broadway London X0 SW1H0DB	Common Shares	05/22/2026	200000	6054730.92

144: Remarks and Signature

Remarks	The shares reported on this Form 144 will be sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 03/28/2025.
Date of Notice	06/24/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/28/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Carmen Zamores as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Venker Eric
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)